About: The RMSD plot of Mpro-3,4-Dihydroxy-2-(5-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-cyclopentyl]-carbamic acid tert-butyl ester complex during 100-ns simulations.

6LU7

Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 Mpro 3

Information

Details.

Scientist
Anbuselvam Mohan,1 Nicole Rendine,2 Mohammed Kassim Sudheer Mohammed,3 Anbuselvam Jeeva,4 Hai-Feng Ji,2 and Venkateswara Rao Talluri
Protein
SARS-CoV-2Mpro
Ligand
[3,4-Dihydroxy-2-(5-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-cyclopentyl]-carbamicacid tert-butyl ester, 2. 1-{[Methyl-(5-methyl-1H-pyrazol-3-ylmethyl)-carbamoyl]-methyl}-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid, 3. 1-{[(1-Methyl-piperidin-2-ylmethyl)-carbamoyl]-methyl}-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid (4-fluoro-phenyl)-amide
Simulation Duration
100ns
InChIKey
NFV(YDJGNLIYQSXAAM-UHFFFAOYSA-N) LPV(KJHKTHWMRKYKJE-SUGCFTRWSA-N ) DRV (CJBJHOAVZSMMDJ-HEXNFIEUSA-N ) RTV(NCDNCNXCDXHOMX-XGKFQTDJSA-N) RBV (IWUCXVSUMQZMFG-AFCXAGJDSA-N )
SMILES
NFV (N(=[V])F) LPV(CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O) DRV(CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N ) RTV(CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O ) RBV (C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N )
Molecular Formula
NFV(FNV) LPV(C37H48N4O5) DRV(C27H37N3O7S) RTV (C37H48N6O5S2) RBV (C8H12N4O5)
Protein Details
Mpro, a cysteine protease plays a critical role in viral protein maturation by cleaning proproteins after their translation into the host cell cytosol. The inhibition of viral protease can reduce the assembly of mature viral particles.
Ligand Details
Works by decreasing the amount of HIV in the blood. Used in treatment of HIV.
Attachments